Dublin 'ideal location' for EMA post-Brexit, says IDA's Tommy Fanning

Before UK Prime Minister Theresa May signed the decree absolute on March 29 for Britain to leave the European Union, Ireland began preparing its bid to become the new home of the European Medicines Agency (EMA), which has thus far been located in London.

Tommy Fanning of IDA Ireland, the foreign investment agency for Ireland, spoke with The Pharma Letter from Brussels - if not the heart then certainly the brain of Europe, where most of the political and regulatory machinery of the EU resides.

Joining him on a political tour of the Belgian capital was Lorraine Nolan of the Health Products Regulatory Authority (HPRA), Ireland’s regulator of medicinal products.